Mr. Speaker, seniors and low income Canadians rely on low cost generic pharmaceuticals for their health. Yet the Minister of Industry has created a regulatory environment for generic drug manufacturers that is so cumbersome and unfair that the supreme court called it a draconian regime.
When will the minister take his regulatory thumb off these drug manufacturers and scratch these unfair rules?